BPC-157 + TB-500 Blend
An equal-mass lyophilized blend of BPC-157 (Body Protective Compound-157) and TB-500 (thymosin beta-4 synthetic analogue). Frequently co-studied in tissue repair, angiogenesis, and cytoskeletal research given their complementary mechanisms — BPC-157 via NO pathway and growth factor signaling, TB-500 via actin-G/F dynamics.
Free COA included · Free shipment protection · 99%+ purity by HPLC & MS · Lyophilized powder
Certificate of Analysis — Included Free
Every batch independently tested by U.S.-accredited labs. Lot-matched COA confirms identity, purity ≥99% by HPLC, and safety screening.
Research Overview
This co-lyophilized blend combines BPC-157 and TB-500 (a synthetic thymosin beta-4 analogue) in equal mass ratios, providing researchers with a single vial containing both compounds for combined mechanistic studies. The two peptides have been studied individually in extensive preclinical literature covering tissue repair, angiogenesis, and inflammation modulation, and are commonly included together in research protocols examining complementary pathways.
BPC-157 is a 15-amino acid peptide derived from the human gastric proteome that has been studied for its effects on nitric oxide synthesis, growth factor expression (EGF, VEGF, FGF), and fibroblast proliferation in in vitro wound models. TB-500 (the active fragment of thymosin beta-4, LKKTETQ) modulates G-actin sequestration, affecting cell migration, cytoskeletal reorganization, and metalloproteinase activity in cell culture models.
Research combining both peptides has examined whether their distinct mechanisms produce additive effects in angiogenesis assays, 3D tissue culture models, and rodent injury studies. The blend format is designed for researchers who would otherwise need to reconstitute and mix the two compounds separately.
All referenced studies are preclinical or in vitro. Not for human use.
Molecular Information
| Full Name / IUPAC | BPC-157 + TB-500 Blend |
| CAS Number | 137525-51-0 / 77591-33-4 |
| Molecular Formula | Co-lyophilized blend |
| Molecular Weight | 1,419.6 + 4,963.5 g/mol (components) |
| Sequence / Structure | BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val + TB-500 Ac-(LKKTETQ)·actin binding domain |
| Appearance | White lyophilized powder (combined) |
| Solubility | Both components soluble in sterile water or bacteriostatic water |
| Format | Lyophilized (freeze-dried) powder |
| SKU | CL-018 |
Quality & Testing
- Purity: ≥99% by HPLC
- Identity: Confirmed by Mass Spectrometry (LC-MS)
- Heavy Metals: Screened; below detection thresholds
- Endotoxin: Tested per LAL assay
- Lot Tracking: Lot number on every vial matches published COA
- Packaging: Nitrogen-purged, sealed glass vials
Storage & Handling
- Short-term: Room temperature (15–25°C), dry, dark — up to 4 weeks
- Long-term: Refrigerated at 2–8°C — up to 18 months lyophilized
- Extended: −20°C; avoid freeze-thaw cycling
- Store at −20°C. Reconstitute in sterile or bacteriostatic water; stable 14–21 days at 4°C.
This compound is supplied for in vitro research and laboratory use only. It is not for human or veterinary use, is not a drug or dietary supplement, and has not been evaluated or approved by the FDA or any regulatory agency for any therapeutic application. Purchasers must be 18 years of age or older and qualified researchers operating in compliance with all applicable local, state, and federal regulations governing research chemicals.
